West Bengal’s Return to Ayushman Bharat‑PMJAY Raises Statutory Authority, Constitutional Federalism and Administrative‑Law Questions

The Government of West Bengal has officially reentered the Ayushman Bharat‑PMJAY health insurance programme, thereby extending the scheme’s benefits to an estimated six crore residents of the state. This rejoining fulfills a pre‑election commitment made by the state’s ruling party, marking a reversal of the earlier decision to withdraw from the centrally administered scheme. Under the programme, eligible families—including workers and senior citizens—are entitled to a cashless treatment entitlement of up to five lakh rupees per year, with the aim of facilitating access to medical services across the country. The decision to reengage with the scheme brings the state’s health‑care delivery system back under the umbrella of the national insurance framework, potentially impacting financing arrangements, administrative coordination, and the legal responsibilities of the state in implementing the scheme’s provisions. By covering nearly six crore people, the move is poised to create a substantial expansion of publicly funded health benefits within the state, thereby raising questions about the statutory basis for the state’s participation, the procedural requirements for reentry, and the potential avenues for judicial review of the administrative action. The legal scrutiny may focus on whether the state’s reentry complied with any notifications, guidelines, or consent mechanisms prescribed under the scheme’s governing framework, and whether affected individuals were afforded appropriate notice and opportunity to claim benefits. Moreover, the rejoining may implicate fiscal responsibilities, prompting analysis of how the allocation of central funds to the state is conditioned upon adherence to statutory criteria and whether the state’s budgetary provisions satisfy the statutory obligations attached to the insurance cover.

One question is whether the state possessed the statutory power to re‑enter the Ayushman Bharat‑PMJAY scheme without a formal amendment to its earlier withdrawal order, and whether the central framework mandates a specific consent procedure for any re‑engagement by a state government. The answer may depend on the interpretative reading of the scheme’s governing regulations, which could be construed to require a written request from the state, followed by an approval letter from the central authority, thereby making the rejoining a conditional administrative act subject to statutory compliance. If the reentry occurred without satisfying such procedural prerequisites, a challenger could argue that the administrative action is ultra vires, inviting a writ petition in the appropriate high court to set aside the decision on the ground of illegality.

Perhaps the more important constitutional issue is whether the state’s participation in a centrally funded health insurance scheme undermines the exclusive legislative competence of the Union over schemes of national importance, or whether it falls within the cooperative federalism model that permits joint implementation under Article 246 of the Constitution. The answer may hinge on whether the scheme is classified as a programme of public health falling under the State List, thereby allowing the state to act autonomously, or whether its financing and administration are deemed a Union subject, necessitating compliance with central policy directives and limiting state discretion. If the latter interpretation prevails, the state’s rejoining could be scrutinised under the doctrine of colourable legislation, with courts assessing whether the state’s action merely cloaks a legislative overreach into a domain reserved for the Union, thereby potentially inviting constitutional challenge.

Perhaps the administrative‑law issue lies in the adequacy of notice and opportunity afforded to the millions of citizens who were previously excluded during the state’s withdrawal, since procedural fairness demands that affected persons be informed of their renewed eligibility and the mechanisms to claim benefits. The answer may depend on whether the state issued a public notification, organized outreach programmes, and established a transparent claims process, as the absence of such procedural safeguards could be grounds for a writ of mandamus compelling the administration to fulfil its statutory duty. A competing view may argue that the scheme’s statutory framework provides for automatic entitlement upon re‑entry without a separate procedural step, thereby limiting the scope of judicial intervention to the legality of the re‑joining decision itself rather than the implementation details.

Perhaps the fiscal‑accountability dimension raises the question of how the central disbursements to the state are conditioned on compliance with statutory fiscal safeguards, and whether the state’s budgetary allocations adequately reflect the projected outflow of funds required to meet the five‑lakh‑rupee per‑year coverage for six crore beneficiaries. The legal position would turn on whether the state’s financial management office is obligated to submit audited accounts and performance reports to the central authority, enabling judicial review of any mis‑allocation or delay that could impair the scheme’s objective of providing cashless treatment nationwide. A fuller legal assessment would require clarity on the specific statutory conditions attaching the central funds, as well as an examination of any grievance‑redress mechanisms available to beneficiaries who might face denial of benefits due to administrative lapses in the re‑engagement process.